Gemcitabine Single or Combination Chemotherapy in Post Anthracycline and Taxane Salvage Treatment of Metastatic Breast Cancer: Retrospective Analysis of 124 Patients

참고문헌 (25)

1. "Second and subsequent lines of chemotherapy for metastatic breast cancer", 13, pp.197~207 (2002)
2. "Gemcitabine : preclinical pharmacology and mechanisms of action", 23, pp.3~15 (1996)
3. "Phase II trial of gemcitabine (2,2’- difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas", pp.29~34 (1994)
4. "Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer A study of the National Cancer Institute of Canada Clinical Trials Group", pp.283~5 (1994)
5. "Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer:a phase II study", 12, pp.1821~6 (1994)
6. "Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days", 30a, pp.417~8 (1994)
7. "Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer", 10, pp.155~162 (1999)
8. "Single-agent gemcitabine is active in previously treated metastatic breast cancer", 60, pp.303~307 (2001)
9. "Gemcitabine as first-line therapy in patients with metastatic breast cancer", 62, pp.2~8 (2002)
10. "Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer", 90, pp.215~221 (2005)
11. "A phase II study of gemcitabine monotherapy in breast cancer refractory to anthracycline and taxane", 34, pp.274~279 (2002)
12. "Cancer of the breast", pp.1399~1487 (2005), Lippincott Williams and Wilkins
13. "High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer", 57, pp.640~646 (2006)
14. "Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer", 23, pp.1401~1408 (2005)
15. "Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer", 20, pp.37~41 (2002)
16. "Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy", 11, pp.873~875 (2000)
17. "Gemcitabine", capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes, 2005, pp.6, 158~162
18. "Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer", 21, pp.588~592 (2003)
19. "Spanish Breast Cancer Research Group. Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer", 22, pp.2587~2593 (2004)
20. "Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer", 20, pp.2812~2823 (2002)
21. "Phase III study of gemcitabine plus vinorelbine (VG) versus vinorelbine (V) in patients with metastatic breast cancer (MBC) previously treated with anthracyclines (A) and taxanes (T)", 24, pp.18~ (2006)
22. "Multicentre phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane- pretreated metastatic breast cancer", 40, pp.536~542 (2004)
23. "Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine", 10, pp.211~215 (1999), Greek Breast Cancer Cooperative Group
24. "Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer", 15, pp.95~99 (2004)
25. "Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer", 16, pp.1289~1296 (2005)

관련 논문AI추천